On Dec. 3, the Japan Society for the Study of Obesity issued a formal statement declaring that diabetes medications such as Mounjaro should not be used for rapid weight loss or excessive dietary restriction. Citing a growing trend of improper usage for dieting purposes, the academic society warned that utilizing these drugs introduces health risks, including vomiting and abdominal pain. The organization plans to publicly release the complete statement on its website on Dec. 5.
Health Risks of Rapid Weight Loss and Ketone Buildup
Certain treatments designed for diabetes and obesity function by suppressing a patient’s appetite, with the diabetes drug Mounjaro facing particular scrutiny over improper use for weight reduction. According to the society, employing medications to trigger rapid weight loss accelerates the breakdown of body fat. This process increases the production of a substance called ketone bodies, which leads to vomiting, abdominal pain, and fatigue. In severe scenarios, the resulting health complications can become life-threatening, causing symptoms such as breathing difficulties and impaired consciousness. Officials noted that these health complications are being reported in individuals who do not suffer from diabetes or obesity.
Did You Know? The Japan Society for the Study of Obesity specifically formulated its new guidance after observing cases of non-diabetic and non-obese individuals using appetite-suppressing diabetes drugs improperly to shed pounds quickly.
Japan Obesity Society Urges Halt to Improper Drug Use
The newly issued guidance explicitly demands that individuals stop utilizing pharmaceutical drugs for excessive dietary restriction, highlighting the negative impact on health. The statement encourages people to carefully evaluate whether losing weight is appropriate for them in the first place. For individuals already taking these medications, the society advises that if health complications arise from elevated ketone levels, they must stop both drug usage and restrictive dieting. Patients experiencing these adverse symptoms are urged to consider seeking evaluation at a medical institution.
Japan society issues statement on improper diabetes drug use for dieting
Why did the Japan Society for the Study of Obesity issue the statement?
The academic organization released the declaration on Dec. 3 in response to the expanding trend of people improperly using diabetes medications, such as Mounjaro, solely for the purpose of dieting and rapid weight loss.
What specific physical dangers are linked to this type of weight loss?
Using medication to force rapid weight loss causes fat breakdown to produce increased levels of ketone bodies. This chemical shift triggers vomiting, abdominal pain, fatigue, and potentially life-threatening issues like breathing difficulties and impaired consciousness.
What steps are patients advised to take if symptoms appear?
The society recommends that anyone experiencing health complications related to elevated ketone bodies immediately stop taking the medication and halt their dietary restrictions, while also considering a visit to a medical institution.
How will the medical community address the rising trend of non-patients seeking metabolic drugs for cosmetic weight loss?
Worth a look